Stefania Bartolini

6.8k total citations · 1 hit paper
104 papers, 3.8k citations indexed

About

Stefania Bartolini is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Stefania Bartolini has authored 104 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 52 papers in Pulmonary and Respiratory Medicine and 39 papers in Oncology. Recurrent topics in Stefania Bartolini's work include Glioma Diagnosis and Treatment (61 papers), Lung Cancer Treatments and Mutations (23 papers) and Brain Metastases and Treatment (21 papers). Stefania Bartolini is often cited by papers focused on Glioma Diagnosis and Treatment (61 papers), Lung Cancer Treatments and Mutations (23 papers) and Brain Metastases and Treatment (21 papers). Stefania Bartolini collaborates with scholars based in Italy, United States and Switzerland. Stefania Bartolini's co-authors include Federico Cappuzzo, Lucio Crinò, Enrico Franceschi, Luca Toschi, Giovanni Luca Ceresoli, Alba A. Brandes, Alicia Tosoni, Vanesa Gregorc, Giovanna Finocchiaro and Elisa Rossi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Stefania Bartolini

97 papers receiving 3.7k citations

Hit Papers

MGMT Promoter Methylation... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
    2008 634 citations Alba A. Brandes, Enrico Franceschi et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stefania Bartolini 2.0k 1.8k 1.4k 1.1k 644 104 3.8k
David M. Peereboom 1.7k 0.9× 1.7k 0.9× 2.2k 1.7× 1.3k 1.2× 613 1.0× 198 4.8k
Bassam Abdulkarim 878 0.4× 1.2k 0.6× 882 0.7× 1.3k 1.2× 1.2k 1.9× 98 3.7k
Alicia Tosoni 1.3k 0.6× 771 0.4× 2.9k 2.2× 1.1k 1.0× 842 1.3× 103 4.2k
Margaret Dugan 1.3k 0.6× 2.5k 1.4× 2.2k 1.6× 1.9k 1.8× 1.4k 2.1× 71 6.2k
In Ah Kim 757 0.4× 987 0.6× 617 0.5× 1.1k 1.0× 874 1.4× 162 3.0k
Miguel Á. Idoate 690 0.3× 1.1k 0.6× 998 0.7× 809 0.8× 458 0.7× 146 3.2k
Shom Goel 1.8k 0.9× 3.1k 1.7× 553 0.4× 2.3k 2.1× 1.5k 2.4× 71 5.8k
Morten Mau‐Sørensen 527 0.3× 1.2k 0.7× 570 0.4× 1.1k 1.0× 541 0.8× 130 2.7k
Juanita Lopez 1.3k 0.6× 2.6k 1.4× 321 0.2× 1.9k 1.8× 821 1.3× 144 4.9k
Naren Ramakrishna 920 0.5× 968 0.5× 514 0.4× 639 0.6× 315 0.5× 56 2.2k

Countries citing papers authored by Stefania Bartolini

Since Specialization
Citations

This map shows the geographic impact of Stefania Bartolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Bartolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Bartolini more than expected).

Fields of papers citing papers by Stefania Bartolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Bartolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Bartolini. The network helps show where Stefania Bartolini may publish in the future.

Co-authorship network of co-authors of Stefania Bartolini

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Bartolini. A scholar is included among the top collaborators of Stefania Bartolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Bartolini. Stefania Bartolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gatto, Lidia, et al.. (2024). Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection. Frontiers in Oncology. 13. 1339266–1339266. 1 indexed citations
3.
Nunno, Vincenzo Di, Lidia Gatto, Alicia Tosoni, et al.. (2024). TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype. Pathology - Research and Practice. 262. 155516–155516.
4.
Nunno, Vincenzo Di, et al.. (2024). Economic income and survival in patients affected by glioblastoma: A systematic review and meta-analysis. Neuro-Oncology Practice. 11(5). 546–555. 4 indexed citations
5.
6.
Nunno, Vincenzo Di, Stefania Bartolini, Lidia Gatto, et al.. (2023). The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?. Cells. 13(1). 44–44. 5 indexed citations
7.
Dieci, Maria Vittoria, Pierfranco Conté, Giancarlo Bisagni, et al.. (2023). Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer. JNCI Journal of the National Cancer Institute. 116(1). 69–80. 2 indexed citations
8.
Nunno, Vincenzo Di, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, & Enrico Franceschi. (2023). Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution. Frontiers in Oncology. 12. 1067252–1067252. 37 indexed citations
9.
Gatto, Lidia, et al.. (2023). DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open. Cancers. 15(12). 3251–3251. 18 indexed citations
10.
Nunno, Vincenzo Di, Giuseppe Minniti, Sofia Asioli, et al.. (2022). Machine learning in neuro-oncology: toward novel development fields. Journal of Neuro-Oncology. 159(2). 333–346. 8 indexed citations
11.
Nunno, Vincenzo Di, Enrico Franceschi, Alicia Tosoni, et al.. (2021). Glioblastoma: Emerging Treatments and Novel Trial Designs. Cancers. 13(15). 3750–3750. 20 indexed citations
12.
Nunno, Vincenzo Di, Enrico Franceschi, Alicia Tosoni, et al.. (2021). Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?. Clinical Drug Investigation. 41(9). 757–773. 1 indexed citations
13.
Minichillo, Santino, Enrico Franceschi, Antonella Mura, et al.. (2017). The role of treatments in IDH mutant molecular astrocytomas. Annals of Oncology. 28. vi76–vi76. 1 indexed citations
14.
15.
Cappuzzo, Federico, C. Ligorio, Luca Toschi, et al.. (2007). EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 2(5). 423–429. 71 indexed citations
16.
Franceschi, Enrico, Giovanni Cavallo, L. Scopece, et al.. (2004). Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. British Journal of Cancer. 91(6). 1038–1044. 41 indexed citations
17.
Cappuzzo, Federico, Francesca Mazzoni, Alessandra Gennari, et al.. (2004). Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. British Journal of Cancer. 90(1). 31–35. 36 indexed citations
18.
Cappuzzo, Federico, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.. (2004). Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 96(15). 1133–1141. 311 indexed citations
19.
Cappuzzo, Federico, Vanesa Gregorc, Elisa Rossi, et al.. (2003). Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC. Journal of Clinical Oncology. 21(14). 2658–2663. 175 indexed citations
20.
Ravaioli, Alessandra, Debora Canuti, Lorenzo Gianni, et al.. (1997). Prognostic factors in hereditary and sporadic breast cancers: analysis of an Italian series of 602 patients. The Breast. 6(5). 275–280. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Peereboom Breakdown of academic impact, for papers by Bassam Abdulkarim Breakdown of academic impact, for papers by Alicia Tosoni Breakdown of academic impact, for papers by Margaret Dugan Breakdown of academic impact, for papers by In Ah Kim Breakdown of academic impact, for papers by Miguel Á. Idoate Breakdown of academic impact, for papers by Shom Goel Breakdown of academic impact, for papers by Morten Mau‐Sørensen Breakdown of academic impact, for papers by Juanita Lopez Breakdown of academic impact, for papers by Naren Ramakrishna
Rankless by CCL
2026